The formulation is designed to support daily nutritional intake and contribute to overall wellness
Other research suggests that GLP-1s may help reduce thromboembolic events, such as deep vein thrombosis (DVT), in people with obesity and autoimmune diseases
Cochrane Database of Systematic Reviews , 4, CD011031
Do not exceed the recommended daily intake/dose
Animal trials reported a 12-15% decrease in total cholesterol and a 30-35% decrease in LDL (bad) cholesterol
Furthermore, chronically, the creation of higher muscle mass speeds metabolism by raising basal metabolic rate allowing individuals to burn more calories, which is important for managing weight, obesity and diabetes (DOnofrio et al., 2023)